Drug analytics in Embase
Learn how to use in-depth indexing in Embase to identify semantic relationships between drugs and diseases and how to use the identified relationships to inform drug development and repositioning.
Drug discovery, development and re-purposing require a deep understanding and investigation of the biomedical literature. Researchers require smart data and analytical tools to uncover drug-disease relationships and drug-drug interactions.
How Embase helps
Recommended by the FDA and EMA for monitoring drug safety in biomedical literature, Embase has a broad biomedical scope, with in-depth coverage of pharmacology, pharmaceutical science and clinical research.
Embase delivers comprehensive drug coverage and unique ‘triple-indexing’ that enables direct linking of drugs, diseases and devices to associated events mentioned in biomedical literature. It enables users to extract semantic relationships between drug-disease; drug-drug; device-disease and device-device.

Embase provides in-depth indexing, intuitive search tools and comprehensive content that users:
Ready to take the next step?
Contact us
Avinash Permraj, Research Scientist in Biotechnology, Management of Scientific Centers uses Embase to keep up with biological processes, novel techniques and new concepts in animal biotechnology and veterinary research data.
Read the customer story (PDF, 613kb)
Retrieving relevant and high quality evidence from the ever-increasing volume of biomedical literature is a challenge. Embase allows you to search the widest possible pool of data with precision. It provides:
Download the Embase Fact Sheet (PDF, 746kb)
Learn how to use in-depth indexing in Embase to identify semantic relationships between drugs and diseases and how to use the identified relationships to inform drug development and repositioning.
Drug repurposing is an important strategy to reduce time to market, decrease costs and improve success rates of drugs. Learn how the smart data found via the triple indexing of Embase enables drug repurposing.
In this webinar, we discussed how drugs, diseases and devices are indexed in Embase and how this enables you to find the information you’re searching for.
Visit the Hive to explore how biotech and pharma start-ups are using Elsevier R&D solutions to solve for early-stage drug discovery and development.
Drug makers are turning their focus from developing blockbuster drugs to making advances in precision medicine treatments. But what will they need to do to succeed?
Precision medicines display high efficacies against their target groups, but they still face the same problems as other drugs: high attrition rates during development, acquired resistance after launch and so on.
Realize the potential of data-driven drug discovery and development with solutions that help you increase research efficiency and ensure a thriving R&D pipeline.
Learn more about Drug Discovery & Development solutions